Our Board of Directors

Chair, Medical Oncologist

Prof Shackleton is Director of Oncology at Alfred Health, Co-Director of Monash Partners Comprehensive Cancer Consortium, Professor of Oncology at Monash University, Director of Cancer Trials Australia, and a Victorian Cancer Agency Clinical Research Fellow. After training in medical oncology in Melbourne, he undertook PhD studies at the Walter and Eliza Hall Institute and post-doctoral work at the University of Michigan, receiving several major prizes including the 2012 Australian Science Minister’s Prize for Life Scientist of the Year.

Deputy Chair, Surgical Oncologist

Andrew Spillane is Professor of Surgical Oncology at the University of Sydney. He is appointed to the Northern Clinical School, Mater and Royal North Shore Hospitals. He is a Faculty Member of Melanoma Institute Australia. He is former President of BreastSurgANZ, Breast Craft Group Lead for BCT, breast disease section editor for ANZ Journal of Surgery and skin oncology editorial board member for Annals of Surgical Oncology and Journal of Surgical Oncology.


Prof Victoria Mar is a Fellow of the Australasian College of Dermatologists and Director of
the Victorian Melanoma Service at the Alfred Hospital. She is an Adjunct Professor at the School of Public Health and Preventive Medicine, Monash University, and is a member of the Cancer Council Australia Melanoma Guidelines Working Group. Prof Mar has an interest in early melanoma diagnosis and surveillance of high-risk individuals.

Surgical Oncologist

Richard chairs the National Melanoma Standards group for the Ministry of Health plus the Auckland Regional Melanoma Multidisciplinary meeting and sits on the executive committees of MELNET and Melanoma New Zealand charity. He is also a Senior Lecturer at the University of Auckland, publishes in numerous academic journals, is a regular presenter at national and international conferences and is actively involved in research and clinical trials.

Cancer Epidemiologist

Prof Michael Kimlin is an internationally renowned leader in cancer research and cancer control. He is trained as a Cancer Epidemiologist and has significant experience and leadership of, and research into, cancer aetiology, risk and control. He has received over $27M in competitive research funding, has more than 215 journal publications, and has a proven track record of undertaking large, multidisciplinary cancer research programs.


Mary Tsouvalakis is a Managing Principal Solicitor, Corporate Legal Advisory at the Victorian Department of Health. Her legal experience spans across two decades advising private and public sector clients on all aspects of commercial law and commercial litigation, with a focus on the provision of legal advice to the health and medical sector. Mary brings to the Board considerable knowledge and experience in government legal frameworks and governance. She also brings to the Board a lived experience with cancer, including skin cancer.


Prof Sophia Zoungas is Head of Monash University’s School of Public Health and Preventive Medicine, and also leads the School’s Metabolism, Ageing and Genomics Division. She is an endocrinologist with clinical appointments at both Alfred Health and Monash Health. She leads clinical and health services research groups, and collaborates extensively in diabetes, cardiovascular disease, kidney disease, and healthy ageing. Sophia has over 250 publications in peer-reviewed journals.

Sharon Van Buerle

BEc GradDipAppSci
Policy and Financial Resources Management

Sharon Van Buerle brings to the Board over 35 years of extensive expertise leading, supporting and managing complex portfolios and international intergovernmental processes. Her management experience spans financial management, strategic planning, budgeting, cross-organisational change, and oversight and governance. Sharon has proven leadership skills, a collaborative approach, is politically astute and strategically aware of organisational requirements as they are negotiated with key stakeholders.